CHF611.50
1.66% today
SIX Swiss Exchange, Sep 03, 12:55 pm CET
ISIN
CH0016440353
Symbol
EMSN
Sector
Industry

EMS-CHEMIE Target price 2025 - Analyst rating & recommendation

EMS-CHEMIE Classifications & Recommendation:

Buy
7%
Hold
33%
Sell
60%

EMS-CHEMIE Price Target

Target Price CHF645.15
Price CHF601.50
Potential
Number of Estimates 8
8 Analysts have issued a price target EMS-CHEMIE 2026 . The average EMS-CHEMIE target price is CHF645.15. This is higher than the current stock price. The highest price target is
CHF787.50 30.92%
register free of charge
, the lowest is
CHF495.91 17.55%
register free of charge
.
A rating was issued by 15 analysts: 1 Analysts recommend EMS-CHEMIE to buy, 5 to hold and 9 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the EMS-CHEMIE stock has an average upside potential 2026 of . Most analysts recommend the EMS-CHEMIE stock at Sale.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion CHF 2.07 2.03
5.40% 2.16%
EBITDA Margin 28.61% 30.45%
15.39% 6.43%
Net Margin 22.25% 23.55%
6.45% 5.83%

9 Analysts have issued a sales forecast EMS-CHEMIE 2025 . The average EMS-CHEMIE sales estimate is

CHF2.0b
Unlock
. This is
2.16% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF2.2b 7.21%
Unlock
, the lowest is
CHF1.9b 8.97%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF2.1b 5.40%
2025
CHF2.0b 2.16%
Unlock
2026
CHF2.1b 4.74%
Unlock
2027
CHF2.2b 5.47%
Unlock
2028
CHF2.3b 4.11%
Unlock
2029
CHF2.4b 4.03%
Unlock
2030
CHF2.6b 5.49%
Unlock
2031
CHF2.7b 3.99%
Unlock
2032
CHF2.8b 3.99%
Unlock

9 EMS-CHEMIE Analysts have issued a net profit forecast 2025. The average EMS-CHEMIE net profit estimate is

CHF477m
Unlock
. This is
3.55% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF525m 13.95%
Unlock
, the lowest is
CHF435m 5.63%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF461m 0.70%
2025
CHF477m 3.55%
Unlock
2026
CHF507m 6.16%
Unlock
2027
CHF543m 7.22%
Unlock

Net Margin

2024 22.25% 6.45%
2025
23.55% 5.83%
Unlock
2026
23.87% 1.36%
Unlock
2027
24.27% 1.68%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share CHF 19.70 20.40
0.72% 3.55%
P/E 29.49
EV/Sales 6.80

9 Analysts have issued a EMS-CHEMIE forecast for earnings per share. The average EMS-CHEMIE EPS is

CHF20.40
Unlock
. This is
3.55% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CHF22.45 13.96%
Unlock
, the lowest is
CHF18.59 5.63%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF19.70 0.72%
2025
CHF20.40 3.55%
Unlock
2026
CHF21.66 6.18%
Unlock
2027
CHF23.22 7.20%
Unlock

P/E ratio

Current 30.53 15.25%
2025
29.49 3.42%
Unlock
2026
27.77 5.83%
Unlock
2027
25.90 6.73%
Unlock

Based on analysts' sales estimates for 2025, the EMS-CHEMIE stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.65 14.96%
2025
6.80 2.20%
Unlock
2026
6.49 4.52%
Unlock
2027
6.15 5.18%
Unlock
2028
5.91 3.95%
Unlock
2029
5.68 3.88%
Unlock
2030
5.39 5.20%
Unlock
2031
5.18 3.84%
Unlock
2032
4.98 3.83%
Unlock

P/S ratio

Current 6.90 13.56%
2025
7.05 2.21%
Unlock
2026
6.73 4.52%
Unlock
2027
6.38 5.18%
Unlock
2028
6.13 3.95%
Unlock
2029
5.89 3.88%
Unlock
2030
5.58 5.20%
Unlock
2031
5.37 3.84%
Unlock
2032
5.16 3.83%
Unlock

Current EMS-CHEMIE Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Jun 30 2025
BERENBERG
Locked
Locked
Locked Mar 31 2025
STIFEL EUROPE
Locked
Locked
Locked Mar 12 2025
RESEARCH PARTNERS AG
Locked
Locked
Locked Feb 09 2025
BERENBERG
Locked
Locked
Locked Dec 11 2024
RESEARCH PARTNERS AG
Locked
Locked
Locked Oct 27 2024
STIFEL EUROPE
Locked
Locked
Locked Oct 22 2024
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Jun 30 2025
Locked
BERENBERG:
Locked
Locked
Mar 31 2025
Locked
STIFEL EUROPE:
Locked
Locked
Mar 12 2025
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Feb 09 2025
Locked
BERENBERG:
Locked
Locked
Dec 11 2024
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Oct 27 2024
Locked
STIFEL EUROPE:
Locked
Locked
Oct 22 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today